Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)

Market Cap	89.95B
Revenue (ttm)	39.19B -4.2%
Net Income	3.65B -55.6%
EPS	375.11 -55.1%
Shares Out	9.46M
PE Ratio	25.35
Forward PE	n/a
Dividend	170.00 (1.78%)
Ex-Dividend Date	Dec 27, 2024

Volume	23,256
Average Volume	25,834
Open	9,450.00
Previous Close	9,410.00
Day's Range	9,390.00 - 9,480.00
52-Week Range	9,200.00 - 10,500.00
Beta	0.53
RSI	44.73
Earnings Date	Mar 19, 2026

About KOSDAQ:072020

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1968
• Employees: 167
• Stock Exchange: KOSDAQ
• Ticker Symbol: 072020

Financial Performance

In 2022, KOSDAQ:072020's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.